Stock ASLN ASLAN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights ASLAN Pharmaceuticals Limited

Equities

ASLN

US04522R2004

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
0.411 USD -2.10% Intraday chart for ASLAN Pharmaceuticals Limited -8.07% -21.28%
05-09 ASLAN Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-08 Asian Equities Traded in the US as American Depositary Receipts Trend Slightly Lower in Wednesday Trading MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ASLAN Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
MT
Aslan Pharmaceuticals to Present Additional Data from Interim Analysis of Trek-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
CI
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher
MT
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
MT
ASLAN Pharmaceuticals Announces Expansion of its Collaboration with Zenyaku Kogyo Co., Ltd. to Investigate Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
CI
Asian Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note in Monday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%
MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
MT
ASLAN Pharmaceuticals Announces Positive Interim Results from Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
CI
Asian Equities Traded in the US as American Depositary Receipts Fall Again in Friday Trading
MT
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday
MT
Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading
MT
ASLAN Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
ASLAN Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Tech, Auto Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASLN Stock
  4. News ASLAN Pharmaceuticals Limited
  5. Highlights